Irish
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
Neurology 1999

Depression: impact and management by the patient and family.

Ní féidir ach le húsáideoirí cláraithe ailt a aistriú
Logáil Isteach / Cláraigh
Sábháiltear an nasc chuig an gearrthaisce
L Cote

Keywords

Coimriú

Prodromal personality features possibly presaging PD include excessive introversion, punctuality, and inflexibility. Neurobehavioral symptoms of PD that might complicate recognition and treatment of depression include loss of initiative, social withdrawal, excessive dependency indecisiveness, fatigue, apprehension about new challenges, and agoraphobia. In connection with this last feature, PD patients should be encouraged to venture out of the house because the extrapyramidal motor system, which is compromised in PD, takes over in a relaxed, familiar setting. Thus, Parkinson patients tend to have more symptoms at home than away from home. The deteriorating cognitive function which may occur in some PD patients may exacerbate social withdrawal and certain fears. Features of major depression in parkinsonian depression parallel those of the uncomplicated variety, but loss of appetite/weight and sleep disturbances may be more severe in parkinsonian depression. Serotonin depletion probably underlies the pathophysiology of this condition, in that cerebrospinal-fluid levels of serotonin's terminal metabolite decline to a greater extent in parkinsonian depression than in uncomplicated PD. After establishing the severity of depression, the clinician can contemplate several management approaches: in addition to group psychotherapy, antidepressants (after discontinuation of selegiline to avoid adverse events), particularly tricyclic antidepressants with low anticholinergic action (i.e., low potential for confusion) or selective serotonin reuptake inhibitors may be administered. Depressive symptoms during "off" periods (i.e., at nadirs of drug levels) may be relatively intractable and warrant patient and family education. Finally, electroconvulsive and light therapy represent appropriate therapeutic modalities for selected patients.

Bí ar ár
leathanach facebook

An bunachar luibheanna míochaine is iomláine le tacaíocht ón eolaíocht

  • Oibreacha i 55 teanga
  • Leigheasanna luibhe le tacaíocht ón eolaíocht
  • Aitheantas luibheanna de réir íomhá
  • Léarscáil GPS idirghníomhach - clibeáil luibheanna ar an láthair (ag teacht go luath)
  • Léigh foilseacháin eolaíochta a bhaineann le do chuardach
  • Cuardaigh luibheanna míochaine de réir a n-éifeachtaí
  • Eagraigh do chuid spéiseanna agus fanacht suas chun dáta leis an taighde nuachta, trialacha cliniciúla agus paitinní

Clóscríobh symptom nó galar agus léigh faoi luibheanna a d’fhéadfadh cabhrú, luibh a chlóscríobh agus galair agus comharthaí a úsáidtear ina choinne a fheiceáil.
* Tá an fhaisnéis uile bunaithe ar thaighde eolaíoch foilsithe

Google Play badgeApp Store badge